Re the GFR data - Let's hope. But if so, why has DM not mentioned the fact that there will be a presentation (or at least that an abstract has been submitted)?

Re the ACC presentation - It's great news that the CHF data are being aired. I find them very exciting. But what's disappointing is that it's a poster presentation. The presentations that are considered by the selection committees to be the most important, and which attract by far the greatest attention at the meetings, are the oral presentations. Perhaps the organizers considered the numbers on the low side. If the FDA has the same view, they could ask for another follow-on trial specifically looking at CHF admissions or cardiac function (conceivably as part of a BT).